CHIKV an infection leads to MCP-induced cellular infiltration while in the inflamed joints, and bone loss may be ameliorated by treatment with an MCP-inhibiting drug, bindarit. Taken jointly, our knowledge expose a Formerly undescribed part for MCPs in CHIKV-induced bone loss: one of recruiting monocytes/OC precursors to joint web-sites and https://theodorey111jug3.develop-blog.com/profile